Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03605433
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Unidade Local de Saúde de Coimbra, EPE
- Registry
-
NCT03605433
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Portugal
- Registry status
- Unknown status
Technical summary
Registry record NCT03605433. Non-randomized; no masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
- Acronym
- SCOOP
- Condition
- Coronary Artery Disease
- Condition
- Saphenous Vein Graft Patency
- Intervention (Drug)
- Rivaroxaban
- Lead sponsor
- Unidade Local de Saúde de Coimbra, EPE
Record details
- Record id
cardio:ct-nct03605433- Content hash
1e610da1b1bd350c91d95399d8f2a67ec1d85e9872a8a29a90476ee0b20058a2